NCT03407664

Brief Summary

An abdominal aortic aneurysm (AAA) is a dilation of the aorta, defined as an aortic diameter of ≥3cm. It is a significant cause of death internationally and in England each year causes c.4,000 deaths with 8,000 patients undergoing preventative surgery. AAA are often asymptomatic and there is a latent period between development and rupture. This represents an opportunity to screen by ultrasound which has been shown in trials to reduce AAA related mortality by half. In England this evidence is based on a randomised trial data from the late nineties, however, since these data were published the number of men identified with AAA has fallen to a current prevalence of just over 1%. Furthermore, similarly designed randomised trials in Western Australia demonstrated no meaningful differences in AAA or cardiovascular deaths. The first aim of our research is to follow men who have been screened for AAA in England in order to establish the medium (5 years) and long term (10+ years) impact of AAA screening on the risk of a AAA, cardiovascular and all-cause morbidity/mortality in a non-trial setting. Men with sub-aneurysms will be examined (Aorta=2.5-2.9cm) as several studies suggest this group is at risk of late rupture. The role of patient pathways to improve uptake of the screening programme will be examined. Current data suggests that the most 'deprived' men in England are the least likely to turn up for screening but the most likely to have an abdominal aneurysm. Outcomes in this group will be analysed including the benefit of a new patient pathway to improve uptake nationally. Lastly, several large studies have demonstrated that a larger aortic diameter may be associated with cardiovascular risk. The addition of aortic diameter to current risk prediction models could improve the accuracy of these models and will be examined.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 23, 2018

Completed
2.4 years until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

March 10, 2020

Status Verified

January 1, 2020

Enrollment Period

6 months

First QC Date

December 13, 2017

Last Update Submit

March 8, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • AAA related mortality in men invited for AAA screening

    Mortality

    10 years

  • AAA related morbidity in men invited for AAA screening

    Admissions to Hospital

    10 years

Secondary Outcomes (3)

  • Medium term mortality

    5 years

  • Cardiovascular risk in men screened for AAA

    10 years

  • Medium term morbidity

    5 years

Study Arms (1)

Men Screened for AAA in England

Men invited into the NHS AAA Screening programme in England in the years 2013-2017.

Other: this field is not applicable

Interventions

We will not be testing an intervention. Only the long term outcomes of men screened for AAA in England.

Men Screened for AAA in England

Eligibility Criteria

Age65 Years - 65 Years
Sexmale
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Men screened for AAA within the NHS AAA Screening programme in England for the period covering 2013-2017; specifically, screening years 2013/14, 2014/15, 2015/16 and 2016/17.

You may qualify if:

  • All men invited to the NHS AAA screening programme in England between the period of 2013-2017
  • Aged 65 years of age at the time of their invitation to the NHS AAA screening programme
  • All men who have consented for their data to be used for the purposes of research

You may not qualify if:

  • \. All men who do not consent for their data to be used for the purposes of research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Leicester

Leicester, LE3 9QP, United Kingdom

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2017

First Posted

January 23, 2018

Study Start

July 1, 2020

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

March 10, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Data will be anonymised and no patient data will be passed outside of the research group. Results will be published in the usual way.

Locations